C

China Baoan Group Co Ltd
SZSE:000009

Watchlist Manager
China Baoan Group Co Ltd
SZSE:000009
Watchlist
Price: 9.5 CNY -0.21% Market Closed
Market Cap: 24.5B CNY
Have any thoughts about
China Baoan Group Co Ltd?
Write Note

China Baoan Group Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

China Baoan Group Co Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
C
China Baoan Group Co Ltd
SZSE:000009
Income from Continuing Operations
ÂĄ1.1B
CAGR 3-Years
-14%
CAGR 5-Years
2%
CAGR 10-Years
11%
CITIC Ltd
HKEX:267
Income from Continuing Operations
ÂĄ104.6B
CAGR 3-Years
1%
CAGR 5-Years
6%
CAGR 10-Years
10%
Fosun International Ltd
HKEX:656
Income from Continuing Operations
ÂĄ3.3B
CAGR 3-Years
-39%
CAGR 5-Years
-30%
CAGR 10-Years
-8%
J
Jiangsu Yueda Investment Co Ltd
SSE:600805
Income from Continuing Operations
-ÂĄ37.4m
CAGR 3-Years
70%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhe Jiang Jian Feng Group Co Ltd
SSE:600668
Income from Continuing Operations
ÂĄ43.7m
CAGR 3-Years
-57%
CAGR 5-Years
-44%
CAGR 10-Years
-19%
B
Beijing Aerospace Changfeng Co Ltd
SSE:600855
Income from Continuing Operations
-ÂĄ268.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

China Baoan Group Co Ltd
Glance View

Market Cap
24.5B CNY
Industry
Industrial Conglomerates

China Baoan Group Co., Ltd., established in 1983, has evolved into a dynamic conglomerate that seamlessly merges tradition with innovation. Rooted initially in the real estate sector, the company expanded its horizons over the decades, venturing into a diverse array of industries. Today, its portfolio encompasses pharmaceuticals, new materials, and high-technology ventures, each segment contributing its distinct thread to the company's rich tapestry. Real estate remains a foundational pillar of its operations, providing a steady revenue base through the development and management of commercial and residential properties across China. With strategic diversification, the company has maneuvered through economic cycles, skillfully leveraging its core competencies to unlock new growth avenues. Beyond the bricks and mortar, China Baoan's venture into pharmaceuticals and new materials signifies its adaptability and pursuit of future-ready sectors. In the pharmaceutical realm, it channels resources into research and development, producing advanced medical solutions and healthcare products that meet the growing demands of the domestic market. Meanwhile, its development of new materials, particularly in lithium-ion batteries and related technologies, aligns with global transitions towards sustainable energy. This sector not only complements its real estate development by aiding innovation in construction materials but also taps into the burgeoning electric vehicle industry, thus opening new revenue streams. Through this intricate blend of legacy and futurism, China Baoan Group crafts its narrative as a versatile power in China's ever-evolving economic landscape, continually seeking opportunities to enhance its footprint both domestically and abroad.

Intrinsic Value
6 CNY
Overvaluation 37%
Intrinsic Value
Price
C

See Also

What is China Baoan Group Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
1.1B CNY

Based on the financial report for Sep 30, 2024, China Baoan Group Co Ltd's Income from Continuing Operations amounts to 1.1B CNY.

What is China Baoan Group Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
11%

Over the last year, the Income from Continuing Operations growth was -54%. The average annual Income from Continuing Operations growth rates for China Baoan Group Co Ltd have been -14% over the past three years , 2% over the past five years , and 11% over the past ten years .

Back to Top